Advisors
Dr Stephen Cash
Dr Cash is currently CEO of NanoCentral. He started his career with ICI covering sales, marketing, logistics, strategic planning, and new business development. In 1992, Dr Cash led the first ICI business unit MBO, establishing Cleveland Chemicals Ltd, later sold to the Yule Catto group. Since then he has worked in new business development and technology scouting for Thomas Swan & Co Ltd, establishing world leading technologies in areas such as carbon nanotube and carbon nanofibre manufacture in addition to a number of start-up companies (Screen Technology plc, was floated on the AIM market). Dr Cash remains a non-executive director of four start-ups created during this time and sits on the advisory board of the Materials Science Department at the University of Cambridge.
Dr Jeffery Lindeman
Dr Lindeman is an esteemed Intellectual Property consultant and patent attourney at J. A. Lindeman LLC. A renowned thought leader in the field, Dr Lindeman is a world-leading expert in legal issues relating to pharmaceutical solid form intellectual property.
Scientific Advisory Board
Nuformix is able to draw upon a pool of recognised leaders in the field of drug solid form and pharmaceutical development, both from an academic and industrial perspective. The Nuformix Scientific Advisory Board is comprised of a highly complimentary group of individuals, active in industry and who continue to research and publish in this area. Their expertise covers the spectrum of solid form product development from rational and high-throughput screening methods, through to characterisation, process scale-up, formulation and bioavailability studies using rapidly dissolving new forms of low solubility drugs.